A detailed history of Freestone Grove Partners LP transactions in Illumina, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 289,732 shares of ILMN stock, worth $28.8 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
289,732
Previous 118,423 144.66%
Holding current value
$28.8 Million
Previous $9.4 Billion 194.21%
% of portfolio
0.21%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$70.3 - $95.41 $12 Million - $16.3 Million
171,309 Added 144.66%
289,732 $27.6 Billion
Q1 2025

May 15, 2025

BUY
$79.34 - $144.22 $9.4 Million - $17.1 Million
118,423 New
118,423 $9.4 Billion

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $15.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Freestone Grove Partners LP Portfolio

Follow Freestone Grove Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Grove Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Grove Partners LP with notifications on news.